Scientists initially created it for type 2 diabetes treatment but discovered its weight reduction benefits along the way
According to current study findings, the guideline from ADA 2023 has designated SGLT-2i and GLP-1 RAs as first-line drugs for T2DM patients with established ASCVD or high cardiovascular risk, and metformin is no longer recommended as first-line therapy for T2DM patients with high cardiovascular risk due to its neutral HF benefits
Without that signal, the body has no reason to preserve them
Semaglutide improves overall metabolic health by enhancing insulin sensitivity and improving lipid profiles
Unmanaged stress, which can affect cortisol levels, sleep, appetite, recovery, and hormone signaling
To date a total of 130 different pathogenic variants have been identified in the G6PD gene